BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 26807543)

  • 1. Galactose conjugated platinum(II) complex targeting the Warburg effect for treatment of non-small cell lung cancer and colon cancer.
    Wu M; Li H; Liu R; Gao X; Zhang M; Liu P; Fu Z; Yang J; Zhang-Negrerie D; Gao Q
    Eur J Med Chem; 2016 Mar; 110():32-42. PubMed ID: 26807543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanistic and biological characteristics of different sugar conjugated 2-methyl malonatoplatinum(II) complexes as new tumor targeting agents.
    Gao X; Liu S; Shi Y; Huang Z; Mi Y; Mi Q; Yang J; Gao Q
    Eur J Med Chem; 2017 Jan; 125():372-384. PubMed ID: 27688191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose conjugated platinum(II) complex: antitumor superiority to oxaliplatin, combination effect and mechanism of action.
    Li H; Gao X; Liu R; Wang Y; Zhang M; Fu Z; Mi Y; Wang Y; Yao Z; Gao Q
    Eur J Med Chem; 2015 Aug; 101():400-8. PubMed ID: 26177447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GLUT1-mediated selective tumor targeting with fluorine containing platinum(II) glycoconjugates.
    Liu R; Fu Z; Zhao M; Gao X; Li H; Mi Q; Liu P; Yang J; Yao Z; Gao Q
    Oncotarget; 2017 Jun; 8(24):39476-39496. PubMed ID: 28467806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly water-soluble platinum(II) complexes as GLUT substrates for targeted therapy: improved anticancer efficacy and transporter-mediated cytotoxic properties.
    Liu P; Lu Y; Gao X; Liu R; Zhang-Negrerie D; Shi Y; Wang Y; Wang S; Gao Q
    Chem Commun (Camb); 2013 Mar; 49(24):2421-3. PubMed ID: 23420130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methyl 6-Amino-6-deoxy-d-pyranoside-Conjugated Platinum(II) Complexes for Glucose Transporter (GLUT)-Mediated Tumor Targeting: Synthesis, Cytotoxicity, and Cellular Uptake Mechanism.
    Li T; Gao X; Yang L; Shi Y; Gao Q
    ChemMedChem; 2016 May; 11(10):1069-77. PubMed ID: 27135196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, Synthesis of Novel Platinum(II) Glycoconjugates, and Evaluation of Their Antitumor Effects.
    Han J; Gao X; Liu R; Yang J; Zhang M; Mi Y; Shi Y; Gao Q
    Chem Biol Drug Des; 2016 Jun; 87(6):867-77. PubMed ID: 26706102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of antitumor azolato-bridged dinuclear platinum(ii) complexes with in vivo antitumor efficacy and unique in vitro cytotoxicity profiles.
    Komeda S; Takayama H; Suzuki T; Odani A; Yamori T; Chikuma M
    Metallomics; 2013 May; 5(5):461-8. PubMed ID: 23608770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel cyclometallated Pt(II)-ferrocene complex induces nuclear FOXO3a localization and apoptosis and synergizes with cisplatin to inhibit lung cancer cell proliferation.
    Cortés R; Tarrado-Castellarnau M; Talancón D; López C; Link W; Ruiz D; Centelles JJ; Quirante J; Cascante M
    Metallomics; 2014 Mar; 6(3):622-33. PubMed ID: 24492855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
    Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
    Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose-conjugated platinum(IV) complexes as tumor-targeting agents: design, synthesis and biological evaluation.
    Wang H; Yang X; Zhao C; Wang PG; Wang X
    Bioorg Med Chem; 2019 Apr; 27(8):1639-1645. PubMed ID: 30852077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-Deoxyglucose conjugated platinum (II) complexes for targeted therapy: design, synthesis, and antitumor activity.
    Mi Q; Ma Y; Gao X; Liu R; Liu P; Mi Y; Fu X; Gao Q
    J Biomol Struct Dyn; 2016 Nov; 34(11):2339-50. PubMed ID: 26524393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of a novel theranostic nanomedicine: synthesis and physicochemical properties of a biocompatible polyphosphazene-platinum(II) conjugate.
    Avaji PG; Park JH; Lee HJ; Jun YJ; Park KS; Lee KE; Choi SJ; Lee HJ; Sohn YS
    Int J Nanomedicine; 2016; 11():837-51. PubMed ID: 27042052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterizations of irofulven cytotoxicity in combination with cisplatin and oxaliplatin in human colon, breast, and ovarian cancer cells.
    Serova M; Calvo F; Lokiec F; Koeppel F; Poindessous V; Larsen AK; Laar ES; Waters SJ; Cvitkovic E; Raymond E
    Cancer Chemother Pharmacol; 2006 Apr; 57(4):491-9. PubMed ID: 16075278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo anti-tumor effects of selected platinum(IV) and dinuclear platinum(II) complexes against lung cancer cells.
    Arsenijevic M; Milovanovic M; Jovanovic S; Arsenijevic N; Markovic BS; Gazdic M; Volarevic V
    J Biol Inorg Chem; 2017 Aug; 22(6):807-817. PubMed ID: 28421385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycosylated Platinum(IV) Complexes as Substrates for Glucose Transporters (GLUTs) and Organic Cation Transporters (OCTs) Exhibited Cancer Targeting and Human Serum Albumin Binding Properties for Drug Delivery.
    Ma J; Wang Q; Huang Z; Yang X; Nie Q; Hao W; Wang PG; Wang X
    J Med Chem; 2017 Jul; 60(13):5736-5748. PubMed ID: 28603992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemosensitization and radiosensitization of human lung and colon cancers by antimitotic agent, ABT-751, in athymic murine xenograft models of subcutaneous tumor growth.
    Jorgensen TJ; Tian H; Joseph IB; Menon K; Frost D
    Cancer Chemother Pharmacol; 2007 May; 59(6):725-32. PubMed ID: 16967299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical efficacy and pharmacokinetics of AP5346, a novel diaminocyclohexane-platinum tumor-targeting drug delivery system.
    Rice JR; Gerberich JL; Nowotnik DP; Howell SB
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2248-54. PubMed ID: 16609041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platinum-acridinylthiourea conjugates show cell line-specific cytotoxic enhancement in H460 lung carcinoma cells compared to cisplatin.
    Hess SM; Mounce AM; Sequeira RC; Augustus TM; Ackley MC; Bierbach U
    Cancer Chemother Pharmacol; 2005 Oct; 56(4):337-43. PubMed ID: 15895232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor activity of oxaliplatin in combination with 5-fluorouracil and the thymidylate synthase inhibitor AG337 in human colon, breast and ovarian cancers.
    Raymond E; Buquet-Fagot C; Djelloul S; Mester J; Cvitkovic E; Allain P; Louvet C; Gespach C
    Anticancer Drugs; 1997 Oct; 8(9):876-85. PubMed ID: 9402315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.